Sep 22nd, 2015
Effective Sept. 3, 2015, the status indicator for HCPCS Level II code Q5101 Injection, Filgrastim (G-CSF), Biosimilar, 1 microgram has changed from E Not paid by Medicare when submitted on outpatient claims (any outpatient bill type) to K Paid under OPPS; separate APC payment. This change is effective Oct. 1, 2015. The Centers for Medicare ...
In Billing
Aug 5th, 2014
With the U.S. Department of Health & Human Services’ (HHS) announcement on July 31 of the new ICD-10 compliance date of October 1, 2015, the Centers for Medicare & Medicaid Services (CMS) released ICD-10 testing information for Medicare fee-for-service (FFS) providers. To help ensure CMS and FFS providers will be ICD-10 complaint by the implementation ...
In Billing
Jun 1st, 2012
July 2012 updates to the Integrated Outpatient Code Editor (I/OCE), the Centers for Medicare & Medicaid Services’ (CMS) system for filing and adjudicating claims paid under the Outpatient Prospective Payment System (OPPS), include a change to bring it in line with correct coding guidelines. The OCE is used for outpatient services in hospitals and ambulatory ...
Apr 12th, 2012
The Centers for Medicare & Medicaid Services (CMS) has instructed fiscal intermediaries (FIs) and Medicare administrative contractors (MACs) to hold claims for the device described by HCPCS Level II code C1882 Cardioverter-defibrillator, other than single or dual chamber (implantable) when reported with the procedure described by CPT® code 33249 Insertion or replacement of permanent pacing ...
In CMS
Mar 16th, 2012
The Centers for Medicare & Medicaid Services (CMS) has posted April 2012 changes to billing instructions for payment policies implemented in the hospital Outpatient Prospective Payment System (OPPS). The April 2012 updated Integrated Outpatient Code Editor (I/OCE) and OPPS Pricer will reflect the HCPCS Level II, ambulatory payment classification (APC), HCPCS modifier, and revenue code ...